Evidence map›Paper›PMID 40593507›Full record

ArticleNature communications2025

DNA polymerase α/primase extraction from chromatin by VCP/p97 restricts ATR activation during unperturbed DNA replication.

Sara Rodríguez-Acebes, Rodrigo Martín-Rufo, Alicia Gómez-Moya, Scott B Churcher, Alejandro Fernández-Llorente, Guillermo de la Vega-Barranco, Alejandra Perona, Pilar Oroz, Elena Martín-Doncel, Luis Ignacio Toledo and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sara Rodríguez-Acebes *DNA Replication Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-9867-7591
Rodrigo Martín-Rufo *Chromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.ORCID http://orcid.org/0000-0003-4219-4846
Alicia Gómez-MoyaChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.
Scott B ChurcherChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.
Alejandro Fernández-LlorenteChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.
Guillermo de la Vega-BarrancoChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.
Alejandra PeronaChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.
Pilar OrozChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain.
Elena Martín-DoncelCenter for Chromosome Stability, Institute for Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Luis Ignacio ToledoCenter for Chromosome Stability, Institute for Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Juan MéndezDNA Replication Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-3235-2559
Emilio LeconaChromatin, Cancer and the Ubiquitin System lab, Centro de Biología Molecular Severo Ochoa (CBM) CSIC-Universidad Autónoma de Madrid, Department of Genome Dynamics and Function, Madrid, Spain. elecona@cbm.csic.es.ORCID http://orcid.org/0000-0002-1687-2562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The replication stress response is an essential pathway that deals with the obstacles that halt the progression of DNA replication forks even during an unperturbed S phase. Basal activation of the ATR and CHK1 kinases prevents the premature firing of origins of replication during S phase, avoiding the activation of an excessive number of replication forks and the appearance of genomic instability. However, the mechanisms that regulate ATR activation in the unperturbed S phase have not been fully determined. Here we present evidence that the AAA ATPase VCP/p97 regulates the presence of the DNA polymerase α/Primase complex (POLA/PRIM) on chromatin, thus limiting its activity and hampering the subsequent activation of ATR by TOPBP1. As a consequence, inhibiting VCP/p97 activates ATR and CHK1 and leads to a cell cycle arrest in G2/M. We propose that the priming activity of POLA/PRIM in the lagging strand is one of the determinants of the basal activation of ATR during an unperturbed S phase and VCP/p97 limits this activation through the extraction of POLA/PRIM from chromatin.

Indexed as

Adenosine TriphosphatasesAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsChromatinDNA Polymerase IDNA PrimaseDNA ReplicationValosin Containing ProteinCarrier ProteinsCheckpoint Kinase 1DNA-Binding ProteinsHeLa CellsHumansNuclear ProteinsS PhaseAdenosine TriphosphatasesAtaxia Telangiectasia Mutated ProteinsATR protein, humanCarrier ProteinsCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanChromatinDNA-Binding ProteinsDNA Polymerase IDNA PrimaseNuclear ProteinsTOPBP1 protein, humanValosin Containing ProteinVCP protein, human

Identifiers

PMID40593507
PMCPMC12219636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.